構造的心臓閉鎖栓：パイプライン製品の分析 - 開発段階、セグメント、地域/国、規制経路、主要企業など (2022年)

当レポートでは、世界の構造的心臓閉鎖栓の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

目次

第1章 目次

第2章 イントロダクション

• 構造的心臓閉鎖栓の概要

第3章 現在治験中の製品

• パイプライン製品：治験段階別
• パイプライン製品：セグメント別
• パイプライン製品：領域別
• パイプライン製品：規制経路別
• パイプライン製品：推定承認時期別
• 現在進行中の治験

第4章 構造的心臓閉鎖栓：各企業で現在治験中のパイプライン製品

• 構造的心臓閉鎖栓の企業：治験段階別のパイプライン製品
• 構造的心臓閉鎖栓：治験段階別のパイプライン製品

第5章 構造的心臓閉鎖栓：企業・製品概要

• Aegis Medical Innovations Inc.：企業概要
• Aporo Biomedical, Inc. (Inactive)：企業概要
• Append Medical：企業概要
• atHeart Medical：企業概要
• AuriGen Medical Ltd：企業概要
• Boston Scientific Corp：企業概要
• CARAG AG：企業概要
• Cierra, Inc. (Inactive)：企業概要
• Conformal Medical Inc：企業概要
• Cor Habere Corp：企業概要
• Dextera Surgical Inc：企業概要
• Ension, Inc.：企業概要
• Guangdong Pulse Medical Technology Co Ltd：企業概要
• Hangzhou Dinova EP Technology Co Ltd：企業概要
• Hansen Medical Inc (Inactive)：企業概要
• Laminar Inc：企業概要
• Lepu Scientech Medical Technology (Shanghai) Co Ltd：企業概要
• Lifetech Scientific (Shenzhen) Co Ltd：企業概要
• LuSeed Vascular：企業概要
• Mayo Clinic：企業概要
• Medtronic Plc：企業概要
• Meril Life Sciences Pvt Ltd：企業概要
• Micro Interventional Devices, Inc.：企業概要
• MicroPort Scientific Corp：企業概要
• Northwestern University：企業概要
• Occlutech International AB：企業概要
• SentreHEART Inc：企業概要
• SeptRx, Inc. (Inactive)：企業概要
• Shanghai Shenqi Medical Technology Co Ltd：企業概要
• Swissimplant AG：企業概要
• The Chaim Sheba Medical Center：企業概要
• University of Minnesota：企業概要
• Vascular Closure Systems Inc：企業概要
• Vascular Concepts Ltd：企業概要
• W. L. Gore & Associates Inc：企業概要

第6章 付録

List of Tables

List of Tables

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials
• Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Structural Heart Occluders under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Structural Heart Occluders under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Structural Heart Occluders Overview

3 Products under Development

• 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
• 3.2 Structural Heart Occluders - Pipeline Products by Segment
• 3.3 Structural Heart Occluders - Pipeline Products by Territory
• 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
• 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• 3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

• 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

• 5.1 Aegis Medical Innovations Inc. Company Overview
• 5.2 Aporo Biomedical, Inc. (Inactive) Company Overview
• 5.3 Append Medical Company Overview
• 5.4 atHeart Medical Company Overview
• 5.5 AuriGen Medical Ltd Company Overview
• 5.6 Boston Scientific Corp Company Overview
• 5.7 CARAG AG Company Overview
• 5.8 Cierra, Inc. (Inactive) Company Overview
• 5.9 Conformal Medical Inc Company Overview
• 5.10 Cor Habere Corp Company Overview
• 5.11 Dextera Surgical Inc Company Overview
• 5.12 Ension, Inc. Company Overview
• 5.13 Guangdong Pulse Medical Technology Co Ltd Company Overview
• 5.14 Hangzhou Dinova EP Technology Co Ltd Company Overview
• 5.15 Hansen Medical Inc (Inactive) Company Overview
• 5.16 Laminar Inc Company Overview
• 5.17 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
• 5.18 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
• 5.19 LuSeed Vascular Company Overview
• 5.20 Mayo Clinic Company Overview
• 5.21 Medtronic Plc Company Overview
• 5.22 Meril Life Sciences Pvt Ltd Company Overview
• 5.23 Micro Interventional Devices, Inc. Company Overview
• 5.24 MicroPort Scientific Corp Company Overview
• 5.25 Northwestern University Company Overview
• 5.26 Occlutech International AB Company Overview
• 5.27 SentreHEART Inc Company Overview
• 5.28 SeptRx, Inc. (Inactive) Company Overview
• 5.29 Shanghai Shenqi Medical Technology Co Ltd Company Overview
• 5.30 Swissimplant AG Company Overview
• 5.31 The Chaim Sheba Medical Center Company Overview
• 5.32 University of Minnesota Company Overview
• 5.33 Vascular Closure Systems Inc Company Overview
• 5.34 Vascular Concepts Ltd Company Overview
• 5.35 W. L. Gore & Associates Inc Company Overview

6 Appendix

• 6.1 Methodology
• 6.2 About GlobalData
• 6.3 Contact Us
• 6.4 Disclaimer